Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 26 Colonic Neoplasms 11 Rectal Neoplasms 10 Colorectal Neoplasms 10 Carcinoma, Non-Small-Cell Lung 9 Uterine Cervical Neoplasms 8 Neoplasms 8 Lung Neoplasms 7 Endometrial Neoplasms 7 Small Cell Lung Carcinoma 6 Prostatic Neoplasms 6 Depression 6 Tobacco Use Disorder 5 Leukemia, Myeloid, Acute 5 Anxiety Disorders 5 Pancreatic Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 4 Breast Carcinoma In Situ 4 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Sexuality 3 Sexual Dysfunction, Physiological 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Overweight 3 Ovarian Neoplasms 3 Obesity 3 Leukemia 3 Fatigue 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3

Interventions

Megestrol Acetate 6 Standard of Care 3 Exercise 3 Physical Therapy Modalities 2 Nutrition Assessment 2 Infliximab 2 Blood Specimen Collection 2 testosterone enanthate 1 remune 1 ostarine 1 olanzapine-fluoxetine combination 1 irinotecan sucrosofate 1 clazakizumab 1 bermekimab 1 anamorelin 1 Sodium Chloride 1 Radiotherapy 1 Preoperative Exercise 1 Powders 1 Pentoxifylline 1 Olanzapine 1 Nandrolone Decanoate 1 Mirtazapine 1 Melatonin 1 Megestrol 1 Immunologic Techniques 1 Ibuprofen 1 High-Energy Shock Waves 1 Ghrelin 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cachexia × Counseling × Clear all

NCT02330926 2025-08-29

MENAC

Norwegian University of Science and Technology

Phase 3 Completed

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡